Long-term remission of small cell lung cancer after reactivation of tuberculosis following immune-checkpoint blockade: A case report

被引：7
|
作者：
Sirgiovanni, Mattia [1 ,2 ]
Hinterleitner, Clemens [1 ,2 ]
Horger, Marius [3 ]
Atique, Naushad Bijoy [1 ,2 ]
Lauer, Ulrich M. [1 ,2 ]
Zender, Lars [1 ,2 ,4 ]
Hinterleitner, Martina [1 ,2 ]
机构：
[1] Univ Hosp Tuebingen, Dept Med Oncol & Pneumol, Tubingen, Germany
[2] Univ Tubingen, Cluster Excellence iFIT EXC Image Guided & Functi, Tubingen, Germany
[3] Univ Hosp Tuebingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany
[4] German Canc Res Ctr, German Canc Res Consortium DKTK, Partner Site Tuebingen, Heidelberg, Germany
来源：
THORACIC CANCER | 2021年 / 12卷 / 05期
关键词：
immune-checkpoint inhibitors; lung cancer; PD-L1; tuberculosis;
D O I：
10.1111/1759-7714.13821
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Immune-checkpoint inhibitors (ICIs) provide a promising treatment option for advanced tumors including small cell lung cancer (SCLC). Nevertheless, in addition to immune-related adverse events (irAEs), an increased risk of infection including tuberculosis has been previously described. Here, we report a case of long-term remission of a patient with SCLC after reactivation of lung tuberculosis following ICI therapy. Our case illustrates the complexity of ICI-associated immune modulation in tuberculosis. Since new lesions in lung cancer patients are commonly associated with tumor progression, infections with mycobacterial tuberculosis may be underdiagnosed in lung cancer.
引用
收藏
页码：699 / 702
页数：4
相关论文
共 50 条
  • [1] Immune checkpoint blockade in small cell lung cancer
    Tay, Rebecca Y.
    Heigener, David
    Reck, Martin
    Califano, Raffaele
    LUNG CANCER, 2019, 137 : 31 - 37
  • [2] Long-Term Intracranial Outcomes With Combination Dual Immune-Checkpoint Blockade and Stereotactic Radiosurgery in Patients With Melanoma and Non-Small Cell Lung Cancer Brain Metastases
    Vaios, Eugene J.
    Shenker, Rachel F.
    Hendrickson, Peter G.
    Wan, Zihan
    Niedzwiecki, Donna
    Winter, Sebastian F.
    Shih, Helen A.
    Dietrich, Jorg
    Wang, Chunhao
    Salama, April K. S.
    Clarke, Jeffrey M.
    Allen, Karen
    Sperduto, Paul
    Mullikin, Trey
    Kirkpatrick, John P.
    Floyd, Scott R.
    Reitman, Zachary J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : 1507 - 1518
  • [3] Clinical and Genomic Characterization of Long-Term Responders Receiving Immune Checkpoint Blockade for Metastatic Non-Small-Cell Lung Cancer
    Ghanem, Paola
    Murray, Joseph C.
    Hsu, Melinda
    Guo, Matthew Z.
    Ettinger, David S.
    Feliciano, Josephine
    Forde, Patrick
    Hann, Christine L.
    Lam, Vincent K.
    Levy, Benjamin
    Anagnostou, Valsamo
    Brahmer, Julie R.
    Marrone, Kristen A.
    CLINICAL LUNG CANCER, 2024, 25 (02) : 109 - 118
  • [4] Immune checkpoint inhibitors in non-small-cell lung cancer: key to long-term survival?
    Dingemans, A-M C.
    Hendriks, L. E. L.
    LANCET RESPIRATORY MEDICINE, 2019, 7 (04): : 291 - 292
  • [5] First-Line Treatment of Advanced Non-Small-Cell Lung Cancer with Immune-Checkpoint Inhibitors: New Combinations and Long-Term Data
    Bossageon, Maxime
    Swalduz, Aurelie
    Chouaid, Christos
    Bylicki, Olivier
    BIODRUGS, 2022, 36 (02) : 137 - 151
  • [6] First-Line Treatment of Advanced Non-Small-Cell Lung Cancer with Immune-Checkpoint Inhibitors: New Combinations and Long-Term Data
    Maxime Boussageon
    Aurélie Swalduz
    Christos Chouaïd
    Olivier Bylicki
    BioDrugs, 2022, 36 : 137 - 151
  • [7] A COMPREHENSIVE CLINICAL AND GENOMIC CHARACTERIZATION OF LONG-TERM RESPONDERS RECEIVING IMMUNE CHECKPOINT BLOCKADE FOR METASTATIC NON-SMALL CELL LUNG CANCER
    Ghanem, Paola
    Murray, Joseph
    Hsu, Melinda
    Ettinger, David
    Feliciano, Josephine
    Forde, Patrick
    Hann, Christine
    Lam, Vincent
    Levy, Benjamin
    Brahmer, Julie
    Marrone, Kristen
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A320 - A320
  • [8] Severe hepatitis related to immune-checkpoint inhibitor in a patient with non-small-cell lung cancer and pulmonary tuberculosis
    Sun, Chuan-Yen
    Shen, Chia-, I
    Feng, Jia-Yih
    Chiang, Chi-Lu
    POSTGRADUATE MEDICAL JOURNAL, 2021, 97 (1151) : 556 - 557
  • [9] Correction to: First-Line Treatment of Advanced Non-Small-Cell Lung Cancer with Immune-Checkpoint Inhibitors: New Combinations and Long-Term Data
    Maxime Boussageon
    Aurélie Swalduz
    Christos Chouaïd
    Olivier Bylicki
    BioDrugs, 2023, 37 : 121 - 121
  • [10] Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade
    Nabet, Barzin
    Hamidi, Habib
    Lee, Myung Chang
    Banchereau, Romain
    Morris, Stefanie
    Adler, Leah
    Gayevskiy, Velimir
    Elhossiny, Ahmed
    Srivastava, Minu
    Patil, Namrata
    Smith, Kiandra
    Jesudason, Rajiv
    Chan, Caleb
    Chang, Patrick
    Fernandez, Matthew
    Rost, Sandra
    Mcginnis, Lisa
    Koeppen, Hartmut
    Gay, Carl
    Minna, John
    Heymach, John
    Chan, Joseph
    Rudin, Charles
    Byers, Lauren
    Liu, Stephen
    Reck, Martin
    Shames, David
    CANCER CELL, 2024, 42 (03) : 429 - 443.e4
12345